TY - JOUR T1 - Transmission of SARS-CoV-2 by children to contacts in schools and households: a prospective cohort and environmental sampling study in London JF - medRxiv DO - 10.1101/2021.03.08.21252839 SP - 2021.03.08.21252839 AU - Rebecca Cordery AU - Lucy Reeves AU - Jie Zhou AU - Aileen Rowan AU - Patricia Watber AU - Carolina Rosadas AU - Michael Crone AU - Marko Storch AU - Paul Freemont AU - Lucy Mosscrop AU - Alice Cowley AU - Gina Zelent AU - Kate Bisset AU - Holly Le Blond AU - Sadie Regmi AU - Christian Buckingham AU - Ramlah Junaideen AU - Nadia Abdulla AU - Joseph Eliahoo AU - Miranda Mindlin AU - Theresa Lamagni AU - Wendy Barclay AU - Graham P. Taylor AU - Shiranee Sriskandan Y1 - 2022/01/01 UR - http://medrxiv.org/content/early/2022/01/02/2021.03.08.21252839.abstract N2 - Background Assessing transmission of SARS-CoV-2 by children in schools is of critical importance to inform public health action. We assessed frequency of acquisition of SARS-CoV-2 by contacts of children with COVID-19 in schools and households, as well as the amount of virus shed into the air and onto fomites in both settings.Methods Cases of COVID-19 in children in London schools were identified via notification. Weekly sampling for 3-4 weeks and PCR testing for SARS-CoV-2 of immediate classroom contacts (the “bubble”), non-bubble school contacts, and household contacts was undertaken supported by genome sequencing, along with surface and air sampling in the school and home environment.Results Within schools, secondary transmission was not detected in 28 individual bubble contacts, representing 10 distinct bubble classes. Across 8 non-bubble classes, 3/62 pupils tested positive– all three were asymptomatic and tested positive in one setting on the same day, unrelated to the original index case. In contrast, the secondary attack rate in naïve household contacts was 14.3% (5/35) rising to 19.1% (9/47) when considering all household contacts. Environmental contamination with SARS-CoV-2 was rare in schools, regardless of school type; fomite SARS-CoV-2 RNA was identified in 4/189 (2.1%) samples in bubble classrooms, 2/127 (1.6%) samples in non-bubble classrooms, and 5/130 (3.8%) samples in washrooms. This contrasted with fomites in households, where SARS-CoV-2 RNA was identified in 60/248 (24.2%) bedroom samples, 66/241 (27.4%) communal room samples, and 21/188 (11.2%) bathroom samples. Air sampling identified SARS-CoV-2 RNA in just 1/68 (1.5%) of school air samples, compared with 21/85 (24.7%) of air samples taken in homes.Summary The low levels of environmental contamination in schools are consistent with low transmission frequency and adequate levels of cleaning and ventilation in schools during the period of study. Secondary transmission in schools was rare. The high frequency of secondary transmission in households associated with evident viral shedding throughout the home suggests a need to improve advice to households with infection in children in order to prevent onward community spread by sibling and adult contacts. The data highlight that transmission from children is very likely to occur when precautions are reduced.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialISRCTN 13773960Funding StatementUKRI/Department of Health & Social Care, National Institute for Health Research (NIHR)Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The protocol was approved by the London (Chelsea) Research Ethics Committee (REC), HRA London Centre, Skipton House, London SE1 6LH (Schools Transmission Study REC reference 18/LO/0025; IRAS Reference 225006). Informed consent was obtained from all participants or parents/guardians, and assent was obtained from any participant aged under 18.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAny data not included in the manuscript are available from the corresponding author upon reasonable request ER -